{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:44:20Z","timestamp":1793699060573,"version":"4.5.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.carrev.2022.04.009","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T20:23:35Z","timestamp":1650918215000},"page":"97-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Clinical Experience of the PK Papyrus Covered Stent in Patients With Coronary Artery Perforations: Results From a Multi-Center Humanitarian Device Exemption Survey"],"prefix":"10.1016","volume":"43","author":[{"given":"David E.","family":"Kandzari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Sarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2022.04.009_bb0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4244\/EIJV8I1A13","article-title":"Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience","volume":"8","author":"Hendry","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2022.04.009_bb0010","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.amjcard.2006.02.041","article-title":"Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft","volume":"98","author":"Lansky","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2022.04.009_bb0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jcin.2010.09.021","article-title":"Coronary perforation: an inconvenient complication","volume":"4","author":"Eeckhout","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.04.009_bb0020","first-page":"966","article-title":"Coronary artery perforations after contemporary percutaneous coronary interventions: evaluation of incidence, risk factors, outcomes, and predictors of mortality","volume":"89","author":"Parsh","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.04.009_bb0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1253\/circj.CJ-19-0757","article-title":"Coronary artery perforation and tamponade - incidence, risk factors, predictors and outcomes from 12 Years' data of the SCAAR registry","volume":"84","author":"Harnek","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2022.04.009_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007049","article-title":"Clinical characteristics and management of coronary artery perforations: a single-center 11-year experience and practical overview","volume":"6","author":"Lemmert","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.carrev.2022.04.009_bb0035","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.4244\/EIJ-D-16-01038","article-title":"Prevalence and outcomes of coronary artery perforation during percutaneous coronary intervention","volume":"13","author":"Guttmann","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2022.04.009_bb0040","first-page":"48","article-title":"Incidence, predictors, management and outcomes of coronary perforations","volume":"93","author":"Shaukat","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.04.009_bb0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jcin.2010.08.026","article-title":"Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation","volume":"4","author":"Al-Lamee","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.04.009_bb0050","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amjcard.2004.09.010","article-title":"Angiographic and clinical outcomes of polytetrafluoroethylene-covered stent use in significant coronary perforations","volume":"95","author":"Ly","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2022.04.009_bb0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0002-8703(03)00505-2","article-title":"Incidence, correlates, management, and clinical outcome of coronary perforation: analysis of 16,298 procedures","volume":"147","author":"Fasseas","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2022.04.009_bb0060","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/01.CIR.102.25.3028","article-title":"Emergency polytetrafluoroethylene-covered stent implantation to treat coronary ruptures","volume":"102","author":"Briguori","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2022.04.009_bb0065","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.4244\/EIJV12I10A210","article-title":"Coronary covered stents","volume":"12","author":"Kilic","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2022.04.009_bb0070","first-page":"353","article-title":"Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results","volume":"56","author":"Gercken","year":"2002","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.04.009_bb0075","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/joic.12525","article-title":"Outcomes after use of covered stents to treat coronary artery perforations. Comparison of old and new-generation covered stents","volume":"31","author":"Hern\u00e1ndez-Enr\u00edquez","year":"2018","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.carrev.2022.04.009_bb5000","unstructured":"https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm620603.htm. Accessed December 31, 2021."},{"key":"10.1016\/j.carrev.2022.04.009_bb0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.carrev.2020.08.017","article-title":"Clinical outcomes after implantation of polyurethane-covered cobalt-chromium stents: insights from the Papyrus-Spain registry","volume":"29","author":"Jurado-Rom\u00e1n","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2022.04.009_bb0085","first-page":"564","article-title":"PK papyrus covered stent: device description and early experience for the treatment of coronary artery perforations","volume":"94","author":"Kandzari","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.04.009_bb0090","first-page":"874","article-title":"Use and outcomes of the PK Papyrus covered stent in France: SOS PK papyrus registry","volume":"98","author":"Hern\u00e1ndez-Enr\u00edquez","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2022.04.009_bb0095","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.4244\/EIJ-D-18-00855","article-title":"Very long-term outcome of coronary covered stents: a report from the SCAAR registry","volume":"14","author":"Harnek","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2022.04.009_bb0100","article-title":"Coronary perforation complicating percutaneous coronary intervention in patients with a history of coronary artery bypass surgery: an analysis of 309 perforation cases from the British Cardiovascular Intervention Society database","volume":"10","author":"Kinnaird","year":"2017","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838922002093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838922002093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:25:39Z","timestamp":1761560739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838922002093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":21,"alternative-id":["S1553838922002093"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2022.04.009","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Experience of the PK Papyrus Covered Stent in Patients With Coronary Artery Perforations: Results From a Multi-Center Humanitarian Device Exemption Survey","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2022.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}